Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension

Abstract Objective: Arterial hypertension (AH) is a risk factor for cardiovascular diseases (CVD). We sought to evaluate the association between two adiposity indices (visceral adiposity index [VAI] and lipid accumulation product [LAP]) with traditional markers of cardiometabolic risk in hypertensi...

Full description

Bibliographic Details
Main Authors: Berilany dos Santos Sena, Fabiana Cristina Lima da Silva Pastich Gonçalves, Regiane Maio, Rebecca Peixoto Paes Silva, Maria da Conceição Chaves de Lemos, Ilma Kruze Grande de Arruda
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2023-01-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000200224&lng=en&tlng=en
_version_ 1797844822175776768
author Berilany dos Santos Sena
Fabiana Cristina Lima da Silva Pastich Gonçalves
Regiane Maio
Rebecca Peixoto Paes Silva
Maria da Conceição Chaves de Lemos
Ilma Kruze Grande de Arruda
author_facet Berilany dos Santos Sena
Fabiana Cristina Lima da Silva Pastich Gonçalves
Regiane Maio
Rebecca Peixoto Paes Silva
Maria da Conceição Chaves de Lemos
Ilma Kruze Grande de Arruda
author_sort Berilany dos Santos Sena
collection DOAJ
description Abstract Objective: Arterial hypertension (AH) is a risk factor for cardiovascular diseases (CVD). We sought to evaluate the association between two adiposity indices (visceral adiposity index [VAI] and lipid accumulation product [LAP]) with traditional markers of cardiometabolic risk in hypertensive patients. Materials and methods: This is a cross-sectional study with 1,273 subjects with hypertension treated as outpatients at a university hospital. The VAI and LAP were calculated using formulas stratified by sex. Cardiometabolic risk variables were considered: overweight, risk for waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHA), and altered biochemical test values. The predictive effect of independent variables on outcomes was assessed by multivariate linear regression analysis. There was statistical significance when p ≤ 0.05. Results: Higher cardiometabolic risk (according to BMI, WHR, WHA, and altered biochemical parameters) was associated with higher values of VAI and LAP with statistical significance (p ≤ 0.05). The regression models used explained 30.7% and 10.5% of the changes in LAP and VAI, respectively. Conclusion: LAP and VAI are associated with cardiometabolic risk parameters in the individuals evaluated, suggesting that these indices can be used to screen for CVD risk in individuals with AH.
first_indexed 2024-04-09T17:29:40Z
format Article
id doaj.art-c43ef8540d4b4d2e91df81d2580611ee
institution Directory Open Access Journal
issn 2359-4292
language English
last_indexed 2024-04-09T17:29:40Z
publishDate 2023-01-01
publisher Brazilian Society of Endocrinology and Metabolism
record_format Article
series Archives of Endocrinology and Metabolism
spelling doaj.art-c43ef8540d4b4d2e91df81d2580611ee2023-04-18T07:35:44ZengBrazilian Society of Endocrinology and MetabolismArchives of Endocrinology and Metabolism2359-42922023-01-0167222423210.20945/2359-3997000000536Visceral adiposity indices and cardiometabolic risk markers in patients with hypertensionBerilany dos Santos Senahttps://orcid.org/0000-0002-9168-3438Fabiana Cristina Lima da Silva Pastich Gonçalveshttps://orcid.org/0000-0002-0275-6392Regiane Maiohttps://orcid.org/0000-0003-1182-8834Rebecca Peixoto Paes Silvahttps://orcid.org/0000-0001-7405-021XMaria da Conceição Chaves de Lemoshttps://orcid.org/0000-0003-3292-7209Ilma Kruze Grande de Arrudahttps://orcid.org/0000-0002-7142-1967Abstract Objective: Arterial hypertension (AH) is a risk factor for cardiovascular diseases (CVD). We sought to evaluate the association between two adiposity indices (visceral adiposity index [VAI] and lipid accumulation product [LAP]) with traditional markers of cardiometabolic risk in hypertensive patients. Materials and methods: This is a cross-sectional study with 1,273 subjects with hypertension treated as outpatients at a university hospital. The VAI and LAP were calculated using formulas stratified by sex. Cardiometabolic risk variables were considered: overweight, risk for waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHA), and altered biochemical test values. The predictive effect of independent variables on outcomes was assessed by multivariate linear regression analysis. There was statistical significance when p ≤ 0.05. Results: Higher cardiometabolic risk (according to BMI, WHR, WHA, and altered biochemical parameters) was associated with higher values of VAI and LAP with statistical significance (p ≤ 0.05). The regression models used explained 30.7% and 10.5% of the changes in LAP and VAI, respectively. Conclusion: LAP and VAI are associated with cardiometabolic risk parameters in the individuals evaluated, suggesting that these indices can be used to screen for CVD risk in individuals with AH.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000200224&lng=en&tlng=enAdipositycardiovascular diseaseshypertensionnutritional status
spellingShingle Berilany dos Santos Sena
Fabiana Cristina Lima da Silva Pastich Gonçalves
Regiane Maio
Rebecca Peixoto Paes Silva
Maria da Conceição Chaves de Lemos
Ilma Kruze Grande de Arruda
Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
Archives of Endocrinology and Metabolism
Adiposity
cardiovascular diseases
hypertension
nutritional status
title Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
title_full Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
title_fullStr Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
title_full_unstemmed Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
title_short Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
title_sort visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
topic Adiposity
cardiovascular diseases
hypertension
nutritional status
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000200224&lng=en&tlng=en
work_keys_str_mv AT berilanydossantossena visceraladiposityindicesandcardiometabolicriskmarkersinpatientswithhypertension
AT fabianacristinalimadasilvapastichgoncalves visceraladiposityindicesandcardiometabolicriskmarkersinpatientswithhypertension
AT regianemaio visceraladiposityindicesandcardiometabolicriskmarkersinpatientswithhypertension
AT rebeccapeixotopaessilva visceraladiposityindicesandcardiometabolicriskmarkersinpatientswithhypertension
AT mariadaconceicaochavesdelemos visceraladiposityindicesandcardiometabolicriskmarkersinpatientswithhypertension
AT ilmakruzegrandedearruda visceraladiposityindicesandcardiometabolicriskmarkersinpatientswithhypertension